European (ethnic group)

Trump’s Pharmaceutical Tariffs Materialize in New US-EU Trade Deal

3 weeks ago talkbio0Tagged 15%, European (ethnic group), Evaluation, pharmaceutical tariffs, Sectioning technique, tariff, trade agreement, Transplant Registry Unified Management Program, U.S., Union, US-EU

Trump; pharmaceutical tariffs; US-EU trade deal; 15% tariff; Section 232 investigation; European Union exports; trade agreement

Biotech Restructuring and European Regulatory Setbacks

5 months ago talkbio0Tagged Commission, European (ethnic group), factor IX, LifeMine, Muscular Dystrophy, Duchenne, regulatory, Translarna

LifeMine Therapeutics, layoffs, PTC Therapeutics, Translarna, Duchenne muscular dystrophy, European Commission, regulatory decision

Gilead’s Seladelpar Receives Conditional EU Approval for Primary Biliary Cholangitis Treatment

6 months ago talkbio0Tagged Biliary Cholangitis, Commission, Conditional, European (ethnic group), Gilead Sciences, Primary Biliary Cholangitis, Response process, seladelpar, ursodiol

Seladelpar, Gilead Sciences, primary biliary cholangitis, PBC, European Commission, conditional marketing authorization, RESPONSE trial, ursodeoxycholic acid (UDCA)

Pfizer’s European Manufacturing Vulnerable to Potential US Tariffs, CEO Warns

6 months ago talkbio0Tagged Albert, Bourla, chain disruption, Drug Industry, European (ethnic group), Manufacturing, Pfizer, Tension, TNFRSF19 gene, U.S.

Pfizer, Albert Bourla, European manufacturing, US tariffs, pharmaceutical industry, trade tensions, supply chain disruption

Galderma’s Nemluvio Secures Dual EU Approvals for Atopic Dermatitis and Prurigo Nodularis

6 months ago talkbio0Tagged Commission approval, Dermatitis, Atopic, European (ethnic group), Galderma, IL-31 receptor alpha, Monoclonal Antibodies, Nemluvio, nemolizumab, nodularis, Prurigo

Nemluvio, nemolizumab, Galderma, European Commission approval, atopic dermatitis, prurigo nodularis, IL-31 receptor alpha, monoclonal antibody

EU Regulator to Investigate Potential Link Between Ozempic and Rare Eye Condition NAION

8 months ago talkbio0Tagged Agencies, Diabetes, European (ethnic group), Evaluation, NAION, Nordisk, Ozempic, semaglutide

Ozempic, NAION, European Medicines Agency, Novo Nordisk, semaglutide, eye disorder, diabetes drug, investigation

European Commission Approves Novo Holdings’ $16.5B Acquisition of Catalent

9 months ago talkbio0Tagged Acquisition, Catalent, Commission, Drug Industry, European (ethnic group), Holdings

Novo Holdings, Catalent, European Commission, Acquisition, Pharmaceutical Industry

Novo Holdings Receives Unconditional EU Approval for $16.5 Billion Acquisition of Catalent

9 months ago talkbio0Tagged Acquisition, Approved, Catalent, Commission, EU, European (ethnic group), Holdings, Pharmaceutical Services

Novo Holdings, Catalent, European Commission, Acquisition, EU Approval, Pharmaceutical Services

European Commission Revokes Marketing Authorization for Ocaliva, a Liver Disease Drug, Amid Regulatory Dispute

9 months ago talkbio0Tagged Advanz Pharma, authorization, Commission, European (ethnic group), Liver diseases, Ocaliva, PBC, Primary Biliary Cholangitis

Ocaliva, European Commission, Marketing Authorization, Liver Disease, Primary Biliary Cholangitis (PBC), Advanz Pharma

European Commission Approves BeiGene’s TEVIMBRA for First-Line Treatment of Advanced/Metastatic Esophageal Squamous Cell Carcinoma and Gastric or Gastroesophageal Junction Cancer

9 months ago talkbio0Tagged BeiGene, Cancer Therapeutic Procedure, Commission approval, European (ethnic group), first-line, Gastroesophageal Junction Adenocarcinoma, Squamous cell carcinoma of esophagus, Stomach, Tevimbra, tislelizumab

TEVIMBRA, tislelizumab, European Commission approval, first-line treatment, esophageal squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, cancer treatment, BeiGene.